Biologics APIs

Oct 16, 2017
By Pharmaceutical Technology Editors
Stelara (ustekinumab), already approved for treating adults, is now also approved for treating adolescents with moderate to severe plaque psoriasis.
Oct 14, 2017
By Pharmaceutical Technology Editors
Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.
Oct 13, 2017
By Pharmaceutical Technology Editors
The committee has voted unanimously to approve Spark Therapeutics’ gene therapy candidate, Luxturna (voretigene neparvovec), for treating a genetically inherited blindness.
Oct 12, 2017
By Pharmaceutical Technology Editors
The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.
Oct 11, 2017
By Pharmaceutical Technology Editors
Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.
Oct 11, 2017
By Pharmaceutical Technology Editors
BARDA has entered a $12-million contract with biopharmaceutical firm Achaogen for the late-stage development of an antibiotic against resistant bacteria, and as a potential treatment for biowarfare agents.
Oct 06, 2017
By Pharmaceutical Technology Editors
Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.
Oct 02, 2017
Pharmaceutical Technology
Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.
Oct 02, 2017
By Pharmaceutical Technology Editors
Sartorius begins building a new, EUR 30-million (US$35.2 million) Cell Culture Technology Center in Ulm, Germany.
Sep 26, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
native1_300x100
lorem ipsum